Balyasny Asset Management’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-438,089
Closed -$15.7M 3437
2022
Q4
$15.7M Buy
+438,089
New +$11M 0.04% 569

Balyasny Asset Management's IMGO Position: Q1 2023 in Review

Balyasny Asset Management sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 438,089 shares — an estimated $15.7M sold.

Balyasny Asset Management first reported a position in IMGO in Q4 2022 and held it in 1 quarter. The position peaked at $15.7M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

  • Balyasny Asset Management reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
  • Balyasny Asset Management sold 438,089 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $15.7M.
  • Balyasny Asset Management first reported a position in Imago BioSciences, Inc. Common stock in Q4 2022 and held it in 1 quarter.
  • Balyasny Asset Management's Imago BioSciences, Inc. Common stock position peaked at $15.7M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Balyasny Asset Management's 13F filing for Q1 2023, filed 15 May 2023.